Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 11, 2020
Reporting Period: Fiscal First Quarter ended March 31, 2020
Context: The filing announces the release of financial results for the first quarter of 2020 via a press release (Exhibit 99.1).
Key Financial Metrics
The provided text is a cover sheet for the 8-K filing and does not contain specific financial data. It references a press release for details but does not list values for:
- Revenue
- Profit or Net Income
- Cash Flow
- Margins
- Debt or Liquidity
Note: The filing text does not provide a clear value for any financial metric.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It only indicates that results for the quarter ended March 31, 2020, have been announced.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It explicitly states that the attached press release is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, limiting the liability of the information contained within the referenced exhibit in this specific document context.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 11, 2020) for actual revenue, earnings, and cash flow figures.
- Verify the specific impact of the fiscal Q1 2020 results on the company's liquidity position.
- Check for any updated guidance or operational risks mentioned in the full press release text.
- Confirm the status of the company as an Emerging Growth Company (indicated as "Yes" in the filing).